GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
#11401-05025 LDL, anti_human
Product name : LDL, anti_human
Catalog number : 11401-05025
Quantity: 400 ug
Supplier name : Assaypro
Data sheet: Ask more or other datasheet now !
About this Product :LDL, anti_human antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of LDL, anti_human.
LDL, anti_human Human samples 80 % of the research is conducted on human samples. GENTAUR suppliers human normal cells, cell lines, RNA extracts and lots of antibodies and ELISA kits to Human proteins as well as LDL, anti_human.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1: Statin Pathway
WP1010: Wnt Signaling Pathway and Pluripotency
WP1016: Wnt Signaling Pathway
WP1041: Statin Pathway
WP1129: Wnt Signaling Pathway and Pluripotency
WP1135: Wnt Signaling Pathway
WP1157: Statin Pathway
WP1288: Wnt Signaling Pathway and Pluripotency
WP1344: Wnt Signaling Pathway and Pluripotency
WP1349: Wnt Signaling Pathway
WP145: Statin Pathway
WP1982: SREBP signalling
WP2011: SREBF and miR33 in cholesterol and lipid homeostasis
WP2084: SREBF and miR33 in cholesterol and lipid homeostasis
WP399: Wnt Signaling Pathway and Pluripotency
WP403: Wnt Signaling Pathway
WP428: Wnt Signaling Pathway
WP430: Statin Pathway
WP564: Wnt Signaling Pathway
WP566: canonical wnt - zebrafish
WP632: Cholesterol metabolism
WP659: Cholesterol metabolism
WP710: DNA damage response (only ATM dependent)
WP723: Wnt Signaling Pathway and Pluripotency
WP779: Wnt Signaling Pathway and Pluripotency
Related Genes :
[LDLR] Low-density lipoprotein receptor (LDL receptor)
[LRP5 LR3 LRP7] Low-density lipoprotein receptor-related protein 5 (LRP-5)
[LRP6] Low-density lipoprotein receptor-related protein 6 (LRP-6)
[Lrp6] Low-density lipoprotein receptor-related protein 6 (LRP-6)
[MYLIP BZF1 IDOL BM-023 PP5242] E3 ubiquitin-protein ligase MYLIP (EC 6.3.2.-) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR)
[APOE] Apolipoprotein E (Apo-E)
[SORL1 C11orf32] Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA)
[Lrp5 Lrp7] Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3)
[Neto1 Btcl1] Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1)
[MALRD1 C10orf112 DIET1] MAM and LDL-receptor class A domain-containing protein 1
[PCSK9 NARC1 PSEC0052] Proprotein convertase subtilisin/kexin type 9 (EC 3.4.21.-) (Neural apoptosis-regulated convertase 1) (NARC-1) (Proprotein convertase 9) (PC9) (Subtilisin/kexin-like protease PC9)
[TINAGL1 GIS5 LCN7 OLRG2 TINAGL PP6614 PSEC0088 UNQ204/PRO230] Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP)
[PKD1] Polycystin-1 (Autosomal dominant polycystic kidney disease 1 protein)
[Malrd1 Diet1 Gm13318] MAM and LDL-receptor class A domain-containing protein 1
[EGF] Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)]
[TLR4] Toll-like receptor 4 (hToll) (CD antigen CD284)
[Lrp8 Apoer2] Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2)
[VLDLR] Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R)
[NETO1 BTCL1] Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1)
[LRP8 APOER2] Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2)
[Sorl1] Sortilin-related receptor (Gp250) (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (mSorLA)
[Tlr4 Lps] Toll-like receptor 4 (CD antigen CD284)
[MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A] Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 184.108.40.206) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a)
[CORIN CRN TMPRSS10] Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment]
[PTPN11 PTP2C SHPTP2] Tyrosine-protein phosphatase non-receptor type 11 (EC 220.127.116.11) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3)
[S100A9 CAGB CFAG MRP14] Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9)
[HSPG2] Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]
[PTK2 FAK FAK1] Focal adhesion kinase 1 (FADK 1) (EC 18.104.22.168) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)
[Mapk14 Crk1 Csbp1 Csbp2] Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 22.214.171.124) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha)
[LCAT] Phosphatidylcholine-sterol acyltransferase (EC 126.96.36.199) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase)
 Circulating Levels of LAMP2 in Coronary Artery Disease: Association with Serum Lipid Profile.
 A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
 Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease.
 Infection, Oxidative Stress and Changes in Circulating Regulatory T cells of Heart Failure Patients Supported by Continuous-Flow Ventricular Assist Devices.
 Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease.
 [OxLDL/β2-glycoprotein I complex as a pro-atherogenic autoantigen. Is atherosclerosis an autoimmune disease?]
 Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver.
 Relationships between FTO rs9939609, MC4R rs17782313, and PPARγ rs1801282 polymorphisms and the occurrence of selected metabolic and hormonal disorders in middle-aged and elderly men - a preliminary study.
 Maternal plasma polyunsaturated fatty acid levels during pregnancy and childhood lipid and insulin levels.
 LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response.
Enter catalog number :